Sort   by:  
 Page size 
UnknownErythropoietin <i>N</i>-glycosylation of Therapeutic Formulations Quantified and Characterized: An Interlab Comparability Study of High-Throughput Methods.
Not available
S-EPMC10813422 | biostudies-literature
ProteomicsCharacterization of human aging and Parkinson’s disease pre-frontal cortex by multi-omics: a glycomics, proteomics study.
This study identifies the age and PD related changes in glycans (HS and CS disaccharides) and proteomics in human aging and Parkinson’s disease. We analyzed the prefrontal cortex for changes in HS, CS and proteomic signatures in young versus aged as well as aged and PD in two cohorts. These studies ...
ORGANISM(S): Homo sapiens (Human) 
2020-07-16 | PXD018736 | Pride
Chondroitin sulfate Mass spectrometry Reverse phase Hilic-wax Multi-omics Label-free proteomics Pre-frontal cortex Heparan sulfate Lc-msms. Proteomic Parkinson’s disease Glycomic Aging 
UnknownSensitive method for glycosaminoglycan analysis of tissue sections.
Not available
S-EPMC6590710 | biostudies-literature
ProteomicsGlycomic and Proteomic changes in aging brain nigrostriatal pathway
This study identifies the age related changes in glycan receptors of heparan sulfate (HS) proteoglycan (receptor for rAAV2), and/or N-glycans with terminal galactose (receptor for rAAV9) and proteomics for receptors and co-receptors of adeno-associated virus in the nigro-striatal region of the brain...
ORGANISM(S): Rattus norvegicus (Rat) 
2018-06-27 | PXD008990 | Pride
Hilic Mass spectrometry Reverse phase Gene therapy Aging nigro-striatal pathway Hilic-wax Lc-msms Label-free proteomics Heparan sulfate Adeno-associated virus N-glycans Proteomic Parkinson’s disease Glycomic 
Sort   by:  
 Page size